Abstract
Studies to support the harms of AASs are limited. Animal work and medical case reports suggest potential to cause serious hepatotoxicity, in addition to possible neurotoxicity, nephrotoxicity and damage to the cardiovascular and reproductive systems. As the long term AAS using cohort reach maturity, further controlled experimentation, with larger sample sizes, is required.
Data gathering should be directed towards establishing knowledge related to the most vulnerable AAS users, which is inclusive of females and adolescent boys.
| Original language | English |
|---|---|
| Journal | British Journal of Pharmacology |
| Early online date | 28 Jan 2020 |
| DOIs | |
| Publication status | E-pub ahead of print - 28 Jan 2020 |
Fingerprint
Cite this
}
Anabolic androgenic steroid abuse in the United Kingdom; an update : the increasing popularity of anabolic androgenic steroids. / Mullen, Carrie; Whalley, Benjamin J.; Schifano, Fabrizio; Baker, Julien S.
In: British Journal of Pharmacology, 28.01.2020.Research output: Contribution to journal › Review article
TY - JOUR
T1 - Anabolic androgenic steroid abuse in the United Kingdom; an update
T2 - the increasing popularity of anabolic androgenic steroids
AU - Mullen, Carrie
AU - Whalley, Benjamin J.
AU - Schifano, Fabrizio
AU - Baker, Julien S.
PY - 2020/1/28
Y1 - 2020/1/28
N2 - Anabolic androgenic steroids (AASs) are prescribed for medical conditions related to low testosterone. Abuse of AASs has surged as they become increasingly recognised as potent image enhancement drugs. The primary goal of most abusers is to obtain what they consider to be a more attractive outward appearance. Abuse is complex. There are a vast range of AAS substances available, although due to their illicit nature, the true composition of AAS substances is difficult to evaluate. Users follow dosing patterns which incorporate a number of different AASs, in addition to other pharmaceutical substances believed to complement the desired physical effects or manage unwanted effects.Studies to support the harms of AASs are limited. Animal work and medical case reports suggest potential to cause serious hepatotoxicity, in addition to possible neurotoxicity, nephrotoxicity and damage to the cardiovascular and reproductive systems. As the long term AAS using cohort reach maturity, further controlled experimentation, with larger sample sizes, is required.Data gathering should be directed towards establishing knowledge related to the most vulnerable AAS users, which is inclusive of females and adolescent boys.
AB - Anabolic androgenic steroids (AASs) are prescribed for medical conditions related to low testosterone. Abuse of AASs has surged as they become increasingly recognised as potent image enhancement drugs. The primary goal of most abusers is to obtain what they consider to be a more attractive outward appearance. Abuse is complex. There are a vast range of AAS substances available, although due to their illicit nature, the true composition of AAS substances is difficult to evaluate. Users follow dosing patterns which incorporate a number of different AASs, in addition to other pharmaceutical substances believed to complement the desired physical effects or manage unwanted effects.Studies to support the harms of AASs are limited. Animal work and medical case reports suggest potential to cause serious hepatotoxicity, in addition to possible neurotoxicity, nephrotoxicity and damage to the cardiovascular and reproductive systems. As the long term AAS using cohort reach maturity, further controlled experimentation, with larger sample sizes, is required.Data gathering should be directed towards establishing knowledge related to the most vulnerable AAS users, which is inclusive of females and adolescent boys.
U2 - 10.1111/bph.14995
DO - 10.1111/bph.14995
M3 - Review article
JO - British Journal of Pharmacology
JF - British Journal of Pharmacology
SN - 0007-1188
ER -